Evaluate MYGN stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in MYGN? | Glauxie AI

Q: What are the risks of investing in MYGN?

Myriad Genetics, Inc. (MYGN) operates in the Medical - Diagnostics & Research industry (Healthcare sector). The company is led by CEO Samraat S. Raha. Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic... Employees: 2,700.

Q: How much debt does MYGN have?

Review MYGN total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is MYGN a good long-term investment?

Evaluate MYGN as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in MYGN?

🦉

Myriad Genetics, Inc. (MYGN)

Company Overview

Sector / IndustryHealthcare / Medical - Diagnostics & Research

CEOSamraat S. Raha

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary...

Key Executives

Name	Title
Benjamin R. Wheeler	Chief Financial Officer & Principal Accounting Officer
Brian Donnelly	Chief Commercial Officer
Dale Muzzey	Chief Scientific Officer
Jennifer L. Fox	Chief Legal Officer
Mark S. Verratti	Chief Operating Officer
Matthew Scalo	Senior Vice President of Investor Relations

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

MYGN Profile Financials

Is MYGN stock safe? How much debt does MYGN have? Is MYGN a good long-term investment?